Frontiers in Veterinary Science (Nov 2023)
Application of the Nagoya Protocol to veterinary pathogens: concerns for the control of foot-and-mouth disease
- Jacquelyn Horsington,
- Elke Abbeloos,
- Labib Bakkali Kassimi,
- Labib Bakkali Kassimi,
- Kingkarn Boonsuya Seeyo,
- Kingkarn Boonsuya Seeyo,
- Alejandra V. Capozzo,
- Eunice Chepkwony,
- Phaedra Eblé,
- Phaedra Eblé,
- Sabrina Galdo-Novo,
- Sabrina Galdo-Novo,
- Daniel Gizaw,
- Lizelle Gouverneur,
- Santina Grazioli,
- Santina Grazioli,
- Livio Heath,
- Livio Heath,
- Pascal Hudelet,
- Joseph M. K. Hyera,
- Joseph M. K. Hyera,
- Martin Ilott,
- Alasdair King,
- David J. Lefebvre,
- David J. Lefebvre,
- David Mackay,
- Samia Metwally,
- Frank N. Mwiine,
- Frank N. Mwiine,
- Charles K. Nfon,
- Charles K. Nfon,
- Min-Kyung Park,
- Edviges Maristela Pituco,
- Fabrizio Rosso,
- Francisco Simon,
- Hussaini G. Ularamu,
- Paul Vermeij,
- Wilna Vosloo,
- Wilna Vosloo,
- Donald P. King,
- Donald P. King
Affiliations
- Jacquelyn Horsington
- European Commission for the Control of Foot-and-Mouth Disease (EuFMD), Rome, Italy
- Elke Abbeloos
- Boehringer Ingelheim Animal Health, Lyon, France
- Labib Bakkali Kassimi
- WOAH/FAO FMD Reference Laboratory Network
- Labib Bakkali Kassimi
- Animal Health Laboratory, UMR1161 Virology, INRAE, ANSES, ENVA, Paris-Est University, Maisons-Alfort, France
- Kingkarn Boonsuya Seeyo
- WOAH/FAO FMD Reference Laboratory Network
- Kingkarn Boonsuya Seeyo
- Regional Reference Laboratory for FMD in Southeast Asia, Pakchong, Thailand
- Alejandra V. Capozzo
- Global Foot-and-Mouth Disease Research Alliance (GFRA)
- Eunice Chepkwony
- Foot and Mouth Disease National Laboratory, Embakasi, Directorate of Veterinary Services, State Department of Livestock, Nairobi, Kenya
- Phaedra Eblé
- WOAH/FAO FMD Reference Laboratory Network
- Phaedra Eblé
- Wageningen Bioveterinary Research (WBVR), Lelystad, Netherlands
- Sabrina Galdo-Novo
- WOAH/FAO FMD Reference Laboratory Network
- Sabrina Galdo-Novo
- Servicio Nacional de Sanidad y Calidad Agroalimentaria (SENASA), Buenos Aires, Argentina
- Daniel Gizaw
- 0Animal Health Institute (AHI), Sebeta, Ethiopia
- Lizelle Gouverneur
- 1FAO World Reference Laboratory for FMD, The Pirbright Institute, Pirbright, United Kingdom
- Santina Grazioli
- WOAH/FAO FMD Reference Laboratory Network
- Santina Grazioli
- 2Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy
- Livio Heath
- WOAH/FAO FMD Reference Laboratory Network
- Livio Heath
- 3Transboundary Animal Disease Laboratory, Onderstepoort Veterinary Institute, Agricultural Research Council, Onderstepoort, South Africa
- Pascal Hudelet
- Boehringer Ingelheim Animal Health, Lyon, France
- Joseph M. K. Hyera
- WOAH/FAO FMD Reference Laboratory Network
- Joseph M. K. Hyera
- 4WOAH Reference Laboratory for FMD, Botswana Vaccine Institute, Lejara, Gaborone, Botswana
- Martin Ilott
- European Commission for the Control of Foot-and-Mouth Disease (EuFMD), Rome, Italy
- Alasdair King
- 5MSD Animal Health, Boxmeer, Netherlands
- David J. Lefebvre
- WOAH/FAO FMD Reference Laboratory Network
- David J. Lefebvre
- 6Sciensano, Scientific Direction of Infectious Diseases in Animals, Service for Exotic and Vector-borne Diseases, Brussels, Belgium
- David Mackay
- European Commission for the Control of Foot-and-Mouth Disease (EuFMD), Rome, Italy
- Samia Metwally
- 7Food and Agriculture Organization of the United Nations (FAO), Rome, Italy
- Frank N. Mwiine
- Global Foot-and-Mouth Disease Research Alliance (GFRA)
- Frank N. Mwiine
- 8College of Veterinary Medicine, Animal Resources, and Biosecurity, Makerere University, Kampala, Uganda
- Charles K. Nfon
- WOAH/FAO FMD Reference Laboratory Network
- Charles K. Nfon
- 9Canadian Food Inspection Agency, National Centre for Foreign Animal Disease, Winnipeg, MB, Canada
- Min-Kyung Park
- 0World Organisation for Animal Health (WOAH), Paris, France
- Edviges Maristela Pituco
- 1Pan American Health Organization, Regional Office for the Americas of the World Health Organization, Rio de Janeiro, Brazil
- Fabrizio Rosso
- European Commission for the Control of Foot-and-Mouth Disease (EuFMD), Rome, Italy
- Francisco Simon
- 2Biogenesis Bago, Buenos Aires, Argentina
- Hussaini G. Ularamu
- 3Viral Research Division, National Veterinary Research Institute, Vom, Nigeria
- Paul Vermeij
- 5MSD Animal Health, Boxmeer, Netherlands
- Wilna Vosloo
- Global Foot-and-Mouth Disease Research Alliance (GFRA)
- Wilna Vosloo
- 4Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Geelong, VIC, Australia
- Donald P. King
- WOAH/FAO FMD Reference Laboratory Network
- Donald P. King
- 1FAO World Reference Laboratory for FMD, The Pirbright Institute, Pirbright, United Kingdom
- DOI
- https://doi.org/10.3389/fvets.2023.1271434
- Journal volume & issue
-
Vol. 10
Abstract
The Nagoya Protocol is an international agreement adopted in 2010 (and entered into force in 2014) which governs access to genetic resources and the fair and equitable sharing of benefits from their utilisation. The agreement aims to prevent misappropriation of genetic resources and, through benefit sharing, create incentives for the conservation and sustainable use of biological diversity. While the equitable sharing of the benefits arising from the utilisation of genetic resources is a widely accepted concept, the way in which the provisions of the Nagoya Protocol are currently being implemented through national access and benefit-sharing legislation places significant logistical challenges on the control of transboundary livestock diseases such as foot-and-mouth disease (FMD). Delays to access FMD virus isolates from the field disrupt the production of new FMD vaccines and other tailored tools for research, surveillance and outbreak control. These concerns were raised within the FMD Reference Laboratory Network and were explored at a recent multistakeholder meeting hosted by the European Commission for the Control of FMD. The aim of this paper is to promote wider awareness of the Nagoya Protocol, and to highlight its impacts on the regular exchange and utilisation of biological materials collected from clinical cases which underpin FMD research activities, and work to develop new epidemiologically relevant vaccines and other diagnostic tools to control the disease.
Keywords
